Related Experiment Video
Updated: Jun 16, 2026

Author Spotlight: Development of an Enhanced Protocol for Rapid and Accurate Isolation of Campylobacter from Food Products
Published on: February 23, 2024
Antimicrobial susceptibilities of Campylobacter fetus: report from a reference laboratory
Ming May Zhang1, Tanner A Melton1, Haris Akhtar2
1Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA.
Abstract:
Campylobacter fetus is known to cause human disease, particularly in elderly and immunocompromised hosts. There are limited published data for antimicrobial susceptibility patterns with this organism, and no interpretive criteria are available. We reviewed antimicrobial susceptibilities of C. fetus isolates tested at a tertiary care center and reference laboratory over an 11-year period. C. fetus isolates from patients treated at Mayo Clinic and those sent as referrals for identification and susceptibility were included. Antimicrobial susceptibility testing was performed using agar dilution for ciprofloxacin, doxycycline, erythromycin, gentamicin, meropenem, and tetracycline. Geographic distribution, culture source, organism minimal inhibitory concentration (MIC) distributions, and MIC50 and MIC90 were examined. Excluding duplicates, 105 unique isolates were identified from 110 positive cultures. Blood cultures represented the most common source, followed by body fluids, skin and soft tissue, and central nervous system. Gentamicin and meropenem had favorable MIC50 and MIC90 of 1 µg/mL. Ciprofloxacin demonstrated an MIC50 of 1 µg/mL; however, the MIC90 was >2 µg/mL. Erythromycin demonstrated MIC50 and MIC90 of 2 µg/mL. Tetracycline and doxycycline were tested on a limited number of isolates and showed a wide range of MICs. Gentamicin and meropenem demonstrated favorable MICs in C. fetus isolates. These may represent therapeutic options for consideration in serious C. fetus infections, pending susceptibility results. Ciprofloxacin, which showed variable results, may be more appropriate for use only after susceptibility testing. C. fetus interpretive criteria are needed to aid clinicians in selection of both empiric and definitive therapies.
Importance:
Our findings contribute to the scant literature on Campylobacter fetus antimicrobial susceptibility test results. We used a reference test method of agar dilution and provide MICs for a large number of organisms and antimicrobial agents.
Insights
Campylobacter fetus infections are a concern for vulnerable populations. Gentamicin and meropenem show promising antimicrobial susceptibility, while ciprofloxacin results vary, highlighting the need for interpretive criteria.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Campylobacter fetus causes disease, especially in elderly and immunocompromised individuals.
- Limited data exist on antimicrobial susceptibility patterns and interpretive criteria for C. fetus.
- This study addresses the need for more information on C. fetus antimicrobial resistance.
Approach:
- Reviewed antimicrobial susceptibilities of 105 unique C. fetus isolates over 11 years.
- Utilized agar dilution method for ciprofloxacin, doxycycline, erythromycin, gentamicin, meropenem, and tetracycline.
- Analyzed minimal inhibitory concentration (MIC) distributions, MIC50, and MIC90.
Key Points:
- Blood cultures were the most common source of C. fetus isolates.
- Gentamicin and meropenem exhibited favorable MIC50 and MIC90 values (1 µg/mL).
- Ciprofloxacin showed variable results (MIC50=1 µg/mL, MIC90=>2 µg/mL), and erythromycin had MIC50/MIC90 of 2 µg/mL.
Conclusions:
- Gentamicin and meropenem are potential therapeutic options for severe C. fetus infections.
- Ciprofloxacin may be suitable only after susceptibility testing due to variable results.
- Development of C. fetus interpretive criteria is crucial for guiding empiric and definitive therapies.
More Related Videos
08:23Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
08:30One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
Related Concept Videos
Microbiota Modulation by Antibiotics
Development of the Oral Microbiota
Clinical Significance of Antibiotic Resistance
Development of Human Microbiota